Skip to main content
Caplight Logo









Niostem

Niostem

Private
CologneHealthcare & Life Scienceshttps://niostem.com/

Last Round

Crowdfunding

Feb 17, 2024

Est. Valuation

$1.04M

Total Funding Raised

$5.05M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Niostem is a German deep-tech company that designs and manufactures wearable devices for hair regrowth using low-level bioelectrical stimulation to reactivate dormant hair follicle stem cells.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, D2C Brands, Consumer Electronics

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

hair loss treatmenthair growth wearableandrogenetic alopeciahair regrowthpattern baldnessbiostimulation deviceelectrical stimulationhair restorationnon-invasive treatmentdrug-free hair lossconsumer medical deviceDTCdirect-to-consumerelectrotrichogenesisbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Niostem Comparables

Compare Niostem with similar companies based on industry and business-model similarity.

Niostem comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kiierr International
87%
Rise Technology
86%
Theradome
85%

Niostem Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingFeb 17, 2024
CrowdfundingJul 1, 2023
SeedJan 18, 2022
AcceleratorApr 1, 2019

Key People

Founding team and executive leadership

Carlos A. Chacón-Martínez

Co-Founder and CTO

Founding Team

Christophe Ramstein

Chief Executive Officer (CEO)

Executive Team

Niostem Investors

Notable investors and investment history

Niostem investors
InvestorRounds
Brightlands Venture PartnersSeed
Entrepreneurs FirstSeed, Accelerator
Cohors Fortuna CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 59% MoM.

  • Jun 21, 2026

    Monthly visitors grew 70% MoM, from 4.4K to 7.5K.

Niostem Filings

Explore SEC and related filing metadata, where available.

Niostem filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Niostem's valuation, stock price, and market status.

Is Niostem a public or private company?

Niostem is a private company.

What is the current stock price of Niostem?

Niostem is a private company with no public stock price. No recent secondary market data is available.

How much is Niostem worth (valuation)?

Niostem's valuation is estimated at $1.0M based on funding round data.

Can I buy Niostem stock?

Niostem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Niostem's last funding round?

Niostem's most recent funding round was Crowdfunding on April 1, 2019.

Who are the main investors in Niostem?

Key investors in Niostem include Brightlands Venture Partners, Entrepreneurs First.

Will Niostem IPO soon?

No public IPO plans have been announced for Niostem.

How can I track Niostem secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Niostem's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCologne
Employee Range10
Year Founded2019
Last FundingFeb 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?